BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 32449421)

  • 41. Prognostic significance of p53, Sox11, and Pax5 co-expression in mantle cell lymphoma.
    Jing C; Zheng Y; Feng Y; Cao X; Xu C
    Sci Rep; 2021 Jun; 11(1):11896. PubMed ID: 34099776
    [TBL] [Abstract][Full Text] [Related]  

  • 42. SOX11 as a minimal residual disease marker for Mantle cell lymphoma.
    Simonsen AT; Sørensen CD; Ebbesen LH; Bødker JS; Bentzen HH; Nyvold CG
    Leuk Res; 2014 Aug; 38(8):918-24. PubMed ID: 24878000
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Plasma cell and terminal B-cell differentiation in mantle cell lymphoma mainly occur in the SOX11-negative subtype.
    Ribera-Cortada I; Martinez D; Amador V; Royo C; Navarro A; Beà S; Gine E; de Leval L; Serrano S; Wotherspoon A; Colomer D; Martinez A; Campo E
    Mod Pathol; 2015 Nov; 28(11):1435-47. PubMed ID: 26360498
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cyclin D1-negative blastoid mantle cell lymphoma identified by SOX11 expression.
    Zeng W; Fu K; Quintanilla-Fend L; Lim M; Ondrejka S; Hsi ED
    Am J Surg Pathol; 2012 Feb; 36(2):214-9. PubMed ID: 22251940
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Genomic and gene expression profiling defines indolent forms of mantle cell lymphoma.
    Fernàndez V; Salamero O; Espinet B; Solé F; Royo C; Navarro A; Camacho F; Beà S; Hartmann E; Amador V; Hernández L; Agostinelli C; Sargent RL; Rozman M; Aymerich M; Colomer D; Villamor N; Swerdlow SH; Pileri SA; Bosch F; Piris MA; Montserrat E; Ott G; Rosenwald A; López-Guillermo A; Jares P; Serrano S; Campo E
    Cancer Res; 2010 Feb; 70(4):1408-18. PubMed ID: 20124476
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The role of SOX11 immunostaining in confirming the diagnosis of mantle cell lymphoma on fine-needle aspiration samples.
    Zhang YH; Liu J; Dawlett M; Guo M; Sun X; Gong Y
    Cancer Cytopathol; 2014 Dec; 122(12):892-7. PubMed ID: 25056830
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Assessment of SOX11 expression in routine lymphoma tissue sections: characterization of new monoclonal antibodies for diagnosis of mantle cell lymphoma.
    Soldini D; Valera A; Solé C; Palomero J; Amador V; Martin-Subero JI; Ribera-Cortada I; Royo C; Salaverria I; Beà S; Gonzalvo E; Johannesson H; Herrera M; Colomo L; Martinez A; Campo E
    Am J Surg Pathol; 2014 Jan; 38(1):86-93. PubMed ID: 24145648
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Polyclonal antibody targeting SOX11 cannot differentiate mantle cell lymphoma from B-cell non-Hodgkin lymphomas.
    Zhang LN; Cao X; Lu TX; Fan L; Wang L; Xu J; Zhang R; Zou ZJ; Wu JZ; Li JY; Xu W
    Am J Clin Pathol; 2013 Dec; 140(6):795-800. PubMed ID: 24225745
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Increased tumour angiogenesis in SOX11-positive mantle cell lymphoma.
    Petrakis G; Veloza L; Clot G; Gine E; Gonzalez-Farre B; Navarro A; Bea S; Martínez A; Lopez-Guillermo A; Amador V; Ribera-Cortada I; Campo E
    Histopathology; 2019 Nov; 75(5):704-714. PubMed ID: 31173643
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Reproducibility of SOX-11 detection in decalcified bone marrow tissue in mantle cell lymphoma patients.
    Righi S; Pileri S; Agostinelli C; Bacci F; Spagnolo S; Sabattini E
    Hum Pathol; 2017 Jan; 59():94-101. PubMed ID: 27720733
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Sox11 promotes head and neck cancer progression via the regulation of SDCCAG8.
    Huang J; Ji EH; Zhao X; Cui L; Misuno K; Guo M; Huang Z; Chen X; Hu S
    J Exp Clin Cancer Res; 2019 Mar; 38(1):138. PubMed ID: 30922366
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Molecular subsets of mantle cell lymphoma defined by the IGHV mutational status and SOX11 expression have distinct biologic and clinical features.
    Navarro A; Clot G; Royo C; Jares P; Hadzidimitriou A; Agathangelidis A; Bikos V; Darzentas N; Papadaki T; Salaverria I; Pinyol M; Puig X; Palomero J; Vegliante MC; Amador V; Martinez-Trillos A; Stefancikova L; Wiestner A; Wilson W; Pott C; Calasanz MJ; Trim N; Erber W; Sander B; Ott G; Rosenwald A; Colomer D; Giné E; Siebert R; Lopez-Guillermo A; Stamatopoulos K; Beà S; Campo E
    Cancer Res; 2012 Oct; 72(20):5307-16. PubMed ID: 22915760
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Diagnostic utility of SOX11 immunohistochemistry in differentiating cutaneous spread of mantle cell lymphoma from primary cutaneous B-cell lymphomas.
    Hsi AC; Hurley MY; Lee SJ; Rosman IS; Pang X; Gru A; Schaffer A
    J Cutan Pathol; 2016 Apr; 43(4):354-61. PubMed ID: 26762898
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Nuclear expression of the non B-cell lineage Sox11 transcription factor identifies mantle cell lymphoma.
    Ek S; Dictor M; Jerkeman M; Jirström K; Borrebaeck CA
    Blood; 2008 Jan; 111(2):800-5. PubMed ID: 17934069
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Molecular Pathogenesis of Mantle Cell Lymphoma.
    Navarro A; Beà S; Jares P; Campo E
    Hematol Oncol Clin North Am; 2020 Oct; 34(5):795-807. PubMed ID: 32861278
    [TBL] [Abstract][Full Text] [Related]  

  • 56. SOX11 expression as a MRD molecular marker for MCL in comparison with t(11;14) and IGH rearrangement.
    Szostakowska M; Szymczyk M; Badowska K; Tudek B; Fabisiewicz A
    Med Oncol; 2018 Mar; 35(4):49. PubMed ID: 29520657
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The role of SOX11 in mantle cell lymphoma.
    Lu TX; Li JY; Xu W
    Leuk Res; 2013 Nov; 37(11):1412-9. PubMed ID: 24001358
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prognostic role of SOX11 in a population-based cohort of mantle cell lymphoma.
    Nygren L; Baumgartner Wennerholm S; Klimkowska M; Christensson B; Kimby E; Sander B
    Blood; 2012 May; 119(18):4215-23. PubMed ID: 22431568
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The expression of SOX11, cyclin D1, cyclin D2, and cyclin D3 in B-cell lymphocytic proliferative diseases.
    Cao X; Fan L; Fang C; Zhu DX; Dong HJ; Wang DM; Wang YH; Xu W; Li JY
    Med Oncol; 2012 Jun; 29(2):1190-6. PubMed ID: 21479697
    [TBL] [Abstract][Full Text] [Related]  

  • 60. SOX11 is useful in differentiating cyclin D1-positive diffuse large B-cell lymphoma from mantle cell lymphoma.
    Hsiao SC; Cortada IR; Colomo L; Ye H; Liu H; Kuo SY; Lin SH; Chang ST; Kuo TU; Campo E; Chuang SS
    Histopathology; 2012 Oct; 61(4):685-93. PubMed ID: 22642745
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.